S3751Referred to Committee
Prescription Drug Supply Chain Pricing Transparency Act
Introduced
2
In Committee3
Passed One Chamber4
Passed Both5
Signed into Law119th
Congress
2026-01-29
Introduced
1
Cosponsors
S
ⓘType
Latest Action
Read twice and referred to the Committee on Finance.
2026-01-29
Bill Summary
This bill, known as the Prescription Drug Supply Chain Pricing Transparency Act, addresses Prescription Drug Supply Chain Pricing Transparency Act. It has been referred to committee for review and possible markup.
Affected Industries
Industries and interest groups with a stake in how this bill is resolved. Compare with each member's outside-money backers on their finance page.
Pharmaceutical
Why this matters: Look up any member who voted on this bill and check their finance page — do the industries listed above match the groups funding their campaigns? That's the kind of connection this tool is built to help you find.
Subjects
Health
Read the full bill text